HG-7-85-01-Decyclopropane

Target: This ligand targets ABL1 kinase, based on the HG-7-85-01 ABL-inhibitor scaffold in biochemical or cellular target-engagement studies.

Mechanism of Action: Used as the target-protein recognition element, this ligand provides the binding interface for ABL1 kinase, based on the HG-7-85-01 ABL-inhibitor scaffold. In PROTAC design, a derivatizable position on the ligand can be connected through an optimized linker to an E3 ligase ligand, such as a CRBN, VHL, or IAP recruiter, while preserving productive target engagement. The resulting bifunctional molecule brings ABL1 kinase into proximity with the recruited E3 ligase, enabling ternary-complex formation. If the complex has favorable geometry and residence time, target lysine ubiquitination is promoted, leading to proteasome-dependent degradation in experimental systems.

• PROTAC-Mediated Target Degradation: HG-7-85-01-Decyclopropane can be used as a binding element to construct PROTACs that recruit an E3 ligase and drive ubiquitination-dependent degradation of the target protein. In research settings, it supports systematic optimization of linker length and attachment geometry to maximize ternary complex formation and degradation potency.

• Ternary Complex Optimization Studies: As a ligand component, HG-7-85-01-Decyclopropane enables evaluation of how binding affinity and spatial orientation influence PROTAC-induced ternary complex stability. Researchers can compare PROTAC variants to identify conditions that enhance cooperative binding, improve residence time, and increase target ubiquitination efficiency.

• Mechanism-of-Degradation Profiling: HG-7-85-01-Decyclopropane-based PROTACs can be applied to dissect degradation mechanisms, including dependence on specific E3 ligase activity and the ubiquitin-proteasome pathway. Experimental designs may include proteasome inhibition, ubiquitination assays, and time-course analyses to distinguish degradation from reversible occupancy.

• Structure–Activity Relationship Mapping: The decyclopropane-containing ligand scaffold supports SAR exploration for PROTAC performance. By systematically modifying conjugation points and linker chemistry while retaining the ligand’s engagement mode, researchers can correlate structural changes with degradation kinetics, maximal knockdown, and selectivity across related proteins.

HG-7-85-01-Decyclopropane is a ABL/Src-family kinase target ligand intended for use as the target-engaging component or reference ligand in PROTAC discovery workflows. Its known small-molecule recognition profile enables rational linker-vector evaluation and comparative degrader design. This molecule is described in detail below.

Structure: The structure of HG-7-85-01-Decyclopropane is characterized by primary or secondary amine/basic nitrogen centers; amide/urea/sulfonamide hydrogen-bonding motifs; halogenated aryl/heteroaryl ring system; heteroaromatic protein-recognition scaffold. These features provide defined hydrogen-bonding, hydrophobic, and steric elements that can support affinity retention while enabling analogue-based linker-vector selection.

Reactivity: The amine/basic nitrogen-containing motif can be evaluated for acylation, sulfonylation, alkylation, or carbamate/urea linker installation when that vector is solvent exposed. For PROTAC construction, the POI ligand can be paired with CRBN ligands such as thalidomide, pomalidomide, or lenalidomide analogues, VHL ligands such as VH032 derivatives, or less common IAP/MDM2/cIAP-recruiting ligands, with alkyl, PEG, piperazine, triazole, or amide linkers screened for ternary-complex formation. In practice, incorporation into PROTACs should begin from derivatives that preserve the reported binding pharmacophore, followed by systematic variation of linker length, polarity, rigidity, and exit-vector geometry to optimize target engagement, E3 recruitment, and cellular degradation readouts.